EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Treatment-naive status and thyroid autoimmunity as determinants of early biochemical thyroid outcome after radioiodine therapy for Graves’ disease: A retrospective cohort study

Shihan Zhang iD, Xiaoyu Ding, Jia Liu, Guang Wang

Science Progress · 2026-10 · 109 (4)

DOI: 10.1177/00368504261504136 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Science Progress, online erschienen am 05.11.2026. Verfasst von Shihan Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Graves Disease, Iodine Radioisotopes, Thyroid Gland, Autoimmunity. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The National Key R&D Program of China, The Beijing Hospitals Authority’s Ascent Plan, The “Qingmiao” Plan Program of Beijing Municipal Hospital Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Early biochemical thyroid outcomes after iodine-131 ( 131 I) therapy for Graves’ disease are heterogeneous. We aimed to identify baseline determinants of 3-month biochemical outcome and assess whether the FT3/FT4 ratio, thyrotroph thyroxine resistance index (TT4RI), or machine-learning algorithms added predictive value.

Methods

We retrospectively reviewed 637 consecutive patients with clinically documented Graves’ disease treated with 131 I between November 2022 and November 2024. Graves’ disease was identified from contemporaneous endocrinologist-recorded diagnoses rather than uniform thyrotropin-receptor antibody confirmation. Three-month thyroid status was classified as persistent overt hyperthyroidism, euthyroidism, or hypothyroidism using institutional biochemical reference ranges; remission was defined as euthyroidism or hypothyroidism. A prespecified multivariable logistic model included age, sex, treatment-naive status, disease duration, goiter grade, administered dose, 24-hour radioactive iodine uptake, thyroid peroxidase antibody (TPOAb), and thyroglobulin antibody. Cross-validated prediction models assessed derived indices and machine-learning algorithms.

Results

At 3 months, 464 patients (72.8%) achieved remission and 369 (57.9%) were hypothyroid. Treatment-naive status and higher TPOAb were independently associated with remission (OR 1.67, 95% CI 1.06–2.62; TPOAb OR 1.11 per log-unit, 1.01–1.23) and hypothyroidism (OR 1.95, 1.29–2.97; TPOAb OR 1.16, 1.06–1.27). Lower goiter grade and higher administered dose were also associated with both outcomes. Discrimination was modest (remission AUC 0.59; hypothyroidism AUC 0.62). Derived indices and machine-learning algorithms did not consistently improve clinically meaningful prediction; an isolated positive continuous NRI for hypothyroidism was not supported by improved AUC or IDI. By 6 months, 273 patients, all hypothyroid at 3 months, had not returned; among reassessed 3-month hypothyroid patients, 21% reverted to euthyroidism.

Conclusions

Treatment-naive status and TPOAb were associated with early biochemical outcome after 131 I therapy, but baseline prediction remained limited. Early hypothyroidism should be interpreted as a 3-month biochemical state rather than definitive ablation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graves DiseaseIodine RadioisotopesThyroid GlandAutoimmunityHumansRetrospective StudiesFemaleMaleMiddle AgedAdultTreatment OutcomeAutoantibodiesMachine Learning

Stichwörter der Autor:innen

Graves’ diseaseearly biochemical outcomehypothyroidismmachine learningprediction modelradioiodineremissionthyroid peroxidase antibody

Substanzen

Iodine RadioisotopesIodine-131Autoantibodies

Autor:innen und Institutionen

  • Department of Endocrinology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Shihan Zhang

Förderung

  • The National Key R&D Program of China
  • The Beijing Hospitals Authority’s Ascent Plan
  • The “Qingmiao” Plan Program of Beijing Municipal Hospital Administration

Zitieren

APA

Zhang, S., Ding, X., Liu, J., & Wang, G. (2026). Treatment-naive status and thyroid autoimmunity as determinants of early biochemical thyroid outcome after radioiodine therapy for Graves’ disease: A retrospective cohort study. Science Progress, 109(4). https://doi.org/10.1177/00368504261504136

Vancouver

Zhang S, Ding X, Liu J, Wang G. Treatment-naive status and thyroid autoimmunity as determinants of early biochemical thyroid outcome after radioiodine therapy for Graves’ disease: A retrospective cohort study. Science Progress. 2026;109(4). doi:10.1177/00368504261504136

BibTeX
@article{Zhang2026,
  author = {Zhang, Shihan and Ding, Xiaoyu and Liu, Jia and Wang, Guang},
  title = {Treatment-naive status and thyroid autoimmunity as determinants of early biochemical thyroid outcome after radioiodine therapy for Graves’ disease: A retrospective cohort study},
  journal = {Science Progress},
  year = {2026},
  volume = {109},
  number = {4},
  doi = {10.1177/00368504261504136}
}
Kostenlos starten →